Sahm Adrangi Takes on the Bull Market with Three New Shorts

While a lot of investors are headed away from hedge funds and other methods that involve fundamental analysis, Sahm Adrangi and his team at Kerrisdale Capital Inc. are still choosing these ways of investing instead of choosing the more mechanical approaches that seem to be popular today. For Sahm Adrangi, it hasn’t been difficult for his company to find success by choosing good stocks for long-term investments while choosing bad stocks to take a short position on. There is still room in the bull market for the type of fundamental investing that Kerrisdale specializes in.

There are a couple of companies that Kerrisdale has taken a short position on that have been garnering a decent amount of interest by investors and the media. One of these is the biotech company called Proteostasis and their leading drug candidate that was designed to treat the crippling disease cystic fibrosis. While their Phase 2 data from testing may appear to be positive, Sahm Adrangi believes that the data released was designed to be intentionally misleading. As a well known activist investor, Sahm Adrangi has shorted the stocks of several other biotech companies who were using the same tactics in order to push an ineffective drug to investors.

Along with Proteostasis, Kerrisdale has their eye on a company in a completely different industry: real estate development. The company St. Joe may have had a good amount of success developing land on beachfront property in Florida, but the same cannot be said for a large tract of land located in Central Florida that can only be best described as swampland. Investors into this development have been waiting for around 10 years to hear news about returns, but they have been rather quiet and there has been little to no progress when it comes to making changes to this property and there is no indication that this will change any time in the near future. In order for the company to meet the expectations and valuations that they had presented to investors, they would have to have sales that would set impressive records throughout the United States.
https://www.prnewswire.com/news-releases/sahm-adrangis-kerrisdale-capital-issues-negative-report-on-the-st-joe-company-and-announces-conference-call-schedule-300635156.html

Leave a Comment